Evidence map›Paper›PMID 24552282›Full record

Trial reportBMC psychiatry2014

The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.

Marco A Bottelier, Marieke L J Schouw, Anne Klomp, Hyke G H Tamminga, Anouk G M Schrantee, Cheima Bouziane, Michiel B de Ruiter, Frits Boer, Henricus G Ruhé, Damiaan Denys and 5 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Marco A Bottelier
Marieke L J Schouw
Anne Klomp
Hyke G H Tamminga
Anouk G M Schrantee
Cheima Bouziane
Michiel B de Ruiter
Frits Boer
Henricus G Ruhé
Damiaan Denys
Roselyne Rijsman
Ramon J L Lindauer
Hans B Reitsma
Hilde M Geurts
Liesbeth RenemanBrain Imaging Center, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. L.Reneman@amc.uva.nl.
Academic Medical Center · NLUniversity of Amsterdam · NLMedisch Centrum Haaglanden · NLUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnimal studies have shown that methylphenidate (MPH) and fluoxetine (FLX) have different effects on dopaminergic and serotonergic system in the developing brain compared to the developed brain. The effects of Psychotropic drugs On the Developing brain (ePOD) study is a combination of different approaches to determine whether there are related findings in humans. METHODS/

designAnimal studies were carried out to investigate age-related effects of psychotropic drugs and to validate new neuroimaging techniques. In addition, we set up two double-blind placebo controlled clinical trials with MPH in 50 boys (10-12 years) and 50 young men (23-40 years) suffering from ADHD (ePOD-MPH) and with FLX in 40 girls (12-14 years) and 40 young women (23-40 years) suffering from depression and anxiety disorders (ePOD-SSRI). Trial registration numbers are: Nederlands Trial Register NTR3103 and NTR2111. A cross-sectional cohort study on age-related effects of these psychotropic medications in patients who have been treated previously with MPH or FLX (ePOD-Pharmo) is also ongoing. The effects of psychotropic drugs on the developing brain are studied using neuroimaging techniques together with neuropsychological and psychiatric assessments of cognition, behavior and emotion. All assessments take place before, during (only in case of MPH) and after chronic treatment. DISCUSSION: The combined results of these approaches will provide new insight into the modulating effect of MPH and FLX on brain development.

Indexed as

AdolescentAdultAnimalsAntidepressive AgentsAnxiety DisordersAttention Deficit Disorder with HyperactivityBrainCentral Nervous System StimulantsChildCross-Sectional StudiesDepressive DisorderDouble-Blind MethodFemaleFluoxetineHumansMaleAntidepressive AgentsCentral Nervous System StimulantsFluoxetineMethylphenidate

Identifiers

PMID24552282
PMCPMC3930821
OpenAlexW2105984088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.